Halozyme Therapeutics: The Losing Streak Continues (HALO)
January 29, 2016 at 12:34 PM EST
Shares of Halozyme Therapeutics (NASDAQ:HALO) traded at a new 52-week low today of $8.26. Approximately 734,000 shares have changed hands today, as compared to an average 30-day volume of...